E Scarr, P H Yu, B A Davis, A A Boulton
Index: Prog. Neuropsychopharmacol. Biol. Psychiatry 15 , 297, (1991)
Full Text: HTML
1. Studies were carried out on three monoamine oxidase (MAO) inhibitors, two of which, debrisoquine and para- hydroxyphenelzine, are purported to be peripheral inhibitors and one, phenelzine, is a peripherally acting inhibitor, which has been included for comparitive purposes. 2. All three showed varying degrees of specificity towards MAO type A. 3. The action of debrisoquine was very rapid as was that of para- hydroxyphenelzine. 4. The inhibition caused by debrisoquine was competitive and reversible, while that caused by both phenelzine and para- hydroxyphenelzine was irreversible. 5. The inhibition caused by debrisoquine appeared to be unaffected by the pH of the medium.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
DEBRISOQUIN SULFATE
CAS:581-88-4 |
C10H13N3.1/2H2O4S |
|
Distinct serum metabolomics profiles associated with maligna...
2015-01-01 [BMC Genomics 16 Suppl 1 , S1, (2015)] |
|
A Comprehensive Metabolomic Investigation in Urine of Mice E...
2015-06-01 [Radiat. Res. 183 , 665-74, (2015)] |
|
Global Metabolomic Identification of Long-Term Dose-Dependen...
2015-08-01 [Radiat. Res. 184 , 121-33, (2015)] |
|
Development of a metabolomic radiation signature in urine fr...
2014-04-01 [Radiat. Res. 181(4) , 350-61, (2014)] |
|
Inactivation of Human Cytochrome P450 3A4 and 3A5 by Droneda...
2016-01-01 [Mol. Pharmacol. 89 , 1-13, (2015)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
